Home stretching device may boost ACL recovery

NCT ID NCT07685561

Not yet recruiting Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial compares standard physical therapy alone versus standard therapy plus daily use of a home stretching device (Ermi Knee Extensionater) for people recovering from ACL reconstruction. Participants are aged 14 to 65 and have had a first-time ACL repair using a patellar tendon graft. The study measures how well the knee can straighten over time. The goal is to see if adding high-intensity stretching at home helps restore full knee extension faster.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ermi Knee Extensionater device
What this could lead to: If it works, this could point toward a more effective home-based rehab approach for regaining full knee motion after ACL surgery.
What could go wrong: This is an early-phase trial with only 58 participants, so results may not apply to everyone. The device requires daily commitment and may cause discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACL KNEE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Alabama at Birmingham

Birmingham, Alabama, 35243, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.